Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Sentien Biotechnologies in April, 2016 for $1,012,556.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HL128659-01 | Phase I | 1,012,556 | April 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Sentien Biotechnologies in August, 2014 for $2,985,949.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK085766-04 | Phase II | 2,985,949 | August 26, 2014 | |||||||
A SBIR Phase II contract was awarded to Sentien Biotechnologies in April, 2016 for $1,571,857.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HL128659-02 | Phase II | 1,571,857 | April 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Sentien Biotechnologies in November, 2011 for $99,974.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-12-C-0034 | Phase I | 99,974 | November 22, 2011 | |||||||
A SBIR Phase II contract was awarded to Sentien Biotechnologies for $773,285.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK085766-03 | Phase II | 773,285 | ||||||||
A SBIR Phase I contract was awarded to Sentien Biotechnologies for $565,011.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK085766-01 | Phase I | 565,011 | ||||||||
A SBIR Phase II contract was awarded to Sentien Biotechnologies for $2,985,949.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK085766-04 | Phase II | 2,985,949 | ||||||||
A SBIR Phase I contract was awarded to Sentien Biotechnologies for $499,306.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK093285-01A1 | Phase I | 499,306 | ||||||||
A SBIR Phase I contract was awarded to Sentien Biotechnologies for $150,000.0 USD from the National Science Foundation. | SBIR | 1013320 | Phase I | 150,000 |